Qiagen NV is a holding company based in the Netherlands. Co. is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. We show 5 historical shares outstanding datapoints in our QGEN shares outstanding history coverage, used to compute QGEN market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing QGEN market cap history over the course of time is important for investors
interested in comparing QGEN's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of QGEN versus a peer is one thing; comparing
QGEN market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like QGEN can fluctuate over the course of history.
With this page we aim to empower investors researching QGEN by allowing them to research the QGEN market cap history. |
Free QGEN Email Alerts:
Video: The Importance of Market Cap
